Harbor Healthcare Announces the Sale & Partnership of Potter’s House Apothecary
PEORIA, AZ. – Harbor Healthcare Consultants is pleased to announce the sale and strategic partnership of Potter’s House Apothecary, a respected provider of sterile and nonsterile compounded medications, to a venture backed healthcare enterprise. Harbor Healthcare Consultants served as the exclusive M&A advisor to Potter’s House Apothecary. The terms of the transaction were not disclosed. […]
MoreHarbor Healthcare Advises The Healthy Choice Compounding Pharmacy on its Sale
New York, NY – Harbor Healthcare Consultants, acting as the exclusive sell-side advisor, today announced the successful completion of the sale of The Healthy Choice Compounding Pharmacy, a New York-based non-sterile 503A compounding pharmacy. The transaction represents another successful closing for Harbor Healthcare Consultants in the growing anti-aging and wellness pharmacy sector. The Healthy Choice […]
More2026 Compounding Pharmacy – Key M&A Considerations for Sellers
Compounding pharmacy remains a sector that competes on innovation, clinical value, and service—not price. Businesses that compete primarily on price simply rearrange the deck chairs on the Titanic. Customer relationships and provider trust drive enterprise value. Sellers must clearly understand the core assets of their company and how the market values them—because when buyers control […]
MoreHarbor Healthcare Advises Midwest Compounders Pharmacy on its Sale
Lenexa, Kansas – Harbor Healthcare is pleased to announce the sale of Midwest Compounders, a 503A sterile compounding pharmacy based in Lenexa, Kansas, to a strategic healthcare investor recognized for deep industry expertise and national relationships. The compounding pharmacy segment has experienced rapid growth over the past decade as integrative medicine has gained recognition and […]
MoreHarbor Healthcare Announces the Sale of Mercury LTC Pharmacy
Harbor Healthcare Consultants is pleased to announce it served as the exclusive sell-side advisor to Mercury Pharmacy Services, a premier long-term care (LTC) pharmacy based in Mountlake Terrace, Washington, in its sale to Guardian Pharmacy Services, one of the nation’s largest LTC pharmacy operators. Founded in 2003, Mercury Pharmacy Services has built a strong regional […]
More2025 Private Equity Update – Healthcare Services & Pharmacy
Other private equity investors might acquire a target to enhance their purchasing power. For example, in the case of a leveraged buyout, the private equity fund would borrow additional money to increase its buying power, using the target acquisition’s assets as collateral. In other cases, the acquisition could grant preferential pricing with key vendors, reducing […]
MoreHarbor Healthcare Announces The Sale Of Meta Pharmacy Services
Nevada – Harbor Healthcare is pleased to announce the sale and partnership of Meta Pharmacy Services, a distinguished 503A nationwide compounding pharmacy providing advanced anti-aging and integrative therapies. The acquirer, a private investor, brings further resources and acumen to the pharmacy. The collaboration signifies a pivotal advancement for the company; one that will foster growth […]
MoreHarbor Healthcare Announces The Sale of a 50,000 sqft 503A Compounding Pharmacy
Missouri – Harbor Healthcare Mergers & Acquisitions, a leading advisory firm specializing in compounding pharmacy transactions, is pleased to announce the successful sale of a 50,000 sqft 503A non-sterile compounding pharmacy, to a nationwide strategic acquirer. The transaction marks an important step in expanding the buyer’s operational capacity and capabilities, enabling broader geographic reach and […]
MoreHarbor Healthcare Successfully Facilitates the Sale of Two Behavioral Health Pharmacies in California
Harbor Healthcare mergers & acquisitions, is pleased to announce the successful sale of two behavioral health pharmacies located in California. The pharmacies, which include a closed-door long-term care (LTC) pharmacy and a retail pharmacy, primarily serve patients with mental health and substance use disorders. The acquisition was made by a private equity-backed strategic pharmacy operator […]
More2024 Behavioral Health LTC Pharmacy Special Report
In my 2023 Market Outlook Report I wrote about how marginalized patient populations and economic inflation can impact pharmacy values. Since publishing that article, Harbor Healthcare closed one of the largest behavioral health pharmacy transactions in the United States. Subsequently, the firm completed and is in the process of completing, several more behavioral health pharmacy […]
More